This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Martini A, Touzani A, Mazzone E, Roumiguié M, Marra G, Valerio M, et al. Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00606-6.
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl J Med. 2016;375:1415–24.
Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg R, Thestrup KC, et al. Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7–10 prostate cancer in biopsy-naïve men. Eur Urol Oncol. 2019; 2. https://doi.org/10.1016/j.euo.2018.09.001.
Kawa SM, Stroomberg HV, Larsen SB, Helgstrand JT, Toft BG, Vickers AJ, et al. A nationwide analysis of risk of prostate cancer diagnosis and mortality following an initial negative TRUS-biopsy with long-term follow-up. J Urol. 2022;208:100–8.
Hilscher M, Røder A, Helgstrand JT, Klemann N, Brasso K, Vickers AJ, et al. Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis. Cancer. 2022;128:3674–3680.
Author information
Authors and Affiliations
Contributions
Conceptualization: HVS, KB, AR; Writing – Original Draft: HVS; Writing – Review & Editing: HVS, KB, AR.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stroomberg, H.V., Brasso, K. & Røder, A. Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen. Prostate Cancer Prostatic Dis 26, 804–805 (2023). https://doi.org/10.1038/s41391-022-00629-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41391-022-00629-z